SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-004063
Filing Date
2004-11-04
Accepted
2004-11-04 13:32:29
Documents
3
Period of Report
2004-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w68386ae8vk.htm 8-K 6326
2 EXHIBIT-99.1 w68386aexv99w1.htm EX-99.1 41534
3 GRAPHIC w68386anovavax.gif GRAPHIC 4058
  Complete submission text file 0000950133-04-004063.txt   53819
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 041118924
SIC: 2836 Biological Products, (No Diagnostic Substances)